Rare diseases
Investigational molecules
Locations
Back to France1 clinical trial in Aubervilliers, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on acute heart attack treatment using a novel therapeutic agent called zalunfiban. The trials aim to evaluate both efficacy and safety in emergency cardiovascular care.
The research specifically targets patients experiencing ST-segment elevation myocardial infarction with persistent chest pain, evaluating treatment outcomes over a 30-day period.
Studies examining rapid intervention protocols for acute cardiac events, focusing on treatment delivery within the critical 4-hour window after symptom onset.
The research emphasizes the importance of early detection and treatment of severe cardiac conditions in pre-hospital settings.
Comprehensive evaluation of bleeding risks and safety parameters using established clinical criteria including GUSTO and BARC classifications.
The research implements rigorous safety protocols to monitor and evaluate potential complications during treatment.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
